Rentokil Initial FY23 Adj. EPS $0.29 Beats $0.28 Estimate, Sales $6.69B Beat $6.67B Estimate
Portfolio Pulse from Benzinga Newsdesk
Rentokil Initial (NYSE:RTO) reported FY23 adjusted EPS of $0.29, surpassing the $0.28 estimate, and sales of $6.69B, exceeding the $6.67B estimate. This represents an 8.71% increase in earnings and a 44.74% increase in sales from the previous year.

March 07, 2024 | 2:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rentokil Initial reported FY23 adjusted EPS of $0.29, beating estimates, and sales of $6.69B, also above expectations. Earnings and sales saw significant increases from the previous year.
Rentokil Initial's reported earnings and sales not only surpassed analyst expectations but also showed substantial growth compared to the previous year. This positive performance, especially in terms of both top and bottom line growth, is likely to instill investor confidence and could lead to a short-term positive impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100